Business1 min read

Novo Nordisk's Wegovy pill beats forecasts as it battles Lilly - Reuters

By · Published by Everything Blog

In short

Novo Nordisk’s oral version of its Wegovy weight-loss drug has outperformed forecasts. The performance comes as the company continues to battle competitor Eli Lilly in the pharmaceutical market.

Key points

  • Novo Nordisk’s oral version of its Wegovy weight-loss drug has outperformed forecasts.: Novo Nordisk’s oral version of its Wegovy weight-loss drug has outperformed forecasts.
  • The performance comes as the company continues to battle competitor Eli Lilly in the phar…: The performance comes as the company continues to battle competitor Eli Lilly in the pharmaceutical market.

Novo Nordisk's Wegovy pill beats forecasts as it battles Lilly    Reuters

Business